Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2019 16:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock

RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
January 09, 2019 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services

RUTHERFORD, N.J. and RESEARCH TRIANGLE PARK, N.C., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics...
December 17, 2018 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Terminates Proposed Merger with NovellusDx

RUTHERFORD, N.J., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
November 19, 2018 16:16 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates

RUTHERFORD, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
November 14, 2018 16:01 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Appoints Glenn Miles as Chief Financial Officer

RUTHERFORD, N.J., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
October 18, 2018 09:05 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China

RUTHERFORD, N.J., Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
October 16, 2018 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Issues Letter to Shareholders

RUTHERFORD, N.J., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
October 08, 2018 07:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics and Cellaria Partner on Precision Medicine Tools

RUTHERFORD, N.J., Oct. 08, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
September 25, 2018 16:01 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Enters Supply Agreement with Agilent Technologies

RUTHERFORD, N.J., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...
September 20, 2018 08:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials

RUTHERFORD, N.J., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and...